Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2019; 14(02): 382-391
DOI: 10.4103/ajns.AJNS_8_19
Review Article

Hypertonic solutions in traumatic brain injury: A systematic review and meta-analysis

Nida Fatima
Department of Neurosurgery, Hamad General Hospital, Doha
,
Ali Ayyad
Department of Neurosurgery, Hamad General Hospital, Doha
,
Ashfaq Shuaib
1   Department of Neuroscience, Hamad General Hospital, Doha, Qatar
2   Department of Neurology, University of Alberta, Edmonton, Alberta, Canada
,
Maher Saqqur
1   Department of Neuroscience, Hamad General Hospital, Doha, Qatar
2   Department of Neurology, University of Alberta, Edmonton, Alberta, Canada
› Author Affiliations
› Further Information
   Permissions and Reprints

This study aims to evaluate the efficacy of hypertonic saline versus crystalloids (normal Saline/lactated Ringers) in improving clinical outcome in patients with traumatic brain injury (TBI). Electronic databases and grey literature (unpublished articles) were searched under different MeSH terms from 1990 to present. Randomized control trials, case–control studies and prospective cohort studies on decompressive craniectomy in TBI (>18-year-old). Clinical outcome measures included Glasgow Coma Outcome Scale (GCOS), Extended GCOS, and mortality. Data were extracted to Review Manager Software. A total of 115 articles that met the inclusion criteria were retrieved and analyzed. Ultimately, five studies were included in our meta-analysis, which revealed that patients with TBI who had hypertonic saline had no statistically significant likelihood of having a good outcome at discharge or 6 months than those who had crystalloid (odds ratio [OR]: 0.01; 95% confidence interval (CI): 0.03–0.05; P = 0.65). The relative risk (RR) of mortality in hypertonic saline versus the crystalloid at discharge or 6-month is RR: 0.80; 95% CI: 0.64–0.99; P = 0.04. The subgroup analysis showed that the group who had hypertonic solution significantly decreases the number of interventions versus the crystalloid group OR: 0.53; 95% CI: 0.48–0.59; P < 0.00001 and also reduces the length of intensive care unit stay (OR: 0.46; 95% CI: 0.21–1.01; P = 0.05). Hypertonic saline decreases the financial burden, but neither impacts the clinical outcome nor reduces the mortality. However, further clinical trials are required to prove if hypertonic saline has any role in improving the clinical and neurological status of patients with TBI versus the normal saline/lactated Ringers.

Key-words:

Clinical outcome - hypertonic saline - traumatic brain injury

Financial support and sponsorship

Nil.




Publication History

Article published online:
09 September 2022

© 2019. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Guerra WK, Gaab MR, Dietz H, Mueller JU, Piek J, Fritsch MJ, et al. Surgical decompression for traumatic brain swelling: Indications and results. J Neurosurg 1999;90:187-96.
  • 2 Maas AI, Dearden M, Teasdale GM, Braakman R, Cohadon F, Iannotti F, et al. EBIC-guidelines for management of severe head injury in adults. European brain injury consortium. Acta Neurochir (Wien) 1997;139:286-94.
  • 3 Marmarou A. Conduct of head injury trials in the United States: The American Brain Injury Consortium (ABIC). Acta Neurochir Suppl 1996;66:118-21.
  • 4 Diringer MN, Videen TO, Yundt K, Zazulia AR, Aiyagari V, Dacey RG Jr., et al. Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury. J Neurosurg 2002;96:103-8.
  • 5 Doerfler A, Forsting M, Reith W, Staff C, Heiland S, Schäbitz WR, et al. Decompressive craniectomy in a rat model of “malignant” cerebral hemispheric stroke: Experimental support for an aggressive therapeutic approach. J Neurosurg 1996;85:853-9.
  • 6 Marshall LF. Head injury: Recent past, present, and future. Neurosurgery 2000;47:546-61.
  • 7 Oertel M, Kelly DF, Lee JH, McArthur DL, Glenn TC, Vespa P, et al. Efficacy of hyperventilation, blood pressure elevation metabolic suppression therapy in controlling intracranial pressure after head injury. J Neurosurg 2002;97:1045-53.
  • 8 Piek J. Decompressive surgery in the treatment of traumatic brain injury. Curr Opin Crit Care 2002;8:134-8.
  • 9 Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 2016;375:1119-30.
  • 10 Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin 1997;13:105-29.
  • 11 Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: Effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg 1992;76:91-8.
  • 12 Wisner DH, Schuster L, Quinn C. Hypertonic saline resuscitation of head injury: Effects on cerebral water content. J Trauma 1990;30:75-8.
  • 13 White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg 2006;102:1836-46.
  • 14 The Brain Trauma Foundation. The American Association of Neurological Surgeons. The joint section on neurotrauma and critical care. Initial management. J Neurotrauma 2000;17:463-9.
  • 15 Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 1990;69:153-9.
  • 16 Roberts I, Schierhout G, Wakai A. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2003;2:CD001049.
  • 17 Weed LH, McKibben PS. Experimental alteration of brain bulk. Am J Physiol 1919;48:531-58.
  • 18 Lazaridis C, Neyens R, Bodle J, DeSantis SM. High-osmolarity saline in neurocritical care: Systematic review and meta-analysis. Crit Care Med 2013;41:1353-60.
  • 19 Ziai WC, Toung TJ, Bhardwaj A. Hypertonic saline:First-line therapy for cerebral edema? J Neurol Sci 2007;261:157-66.
  • 20 Videen TO, Zazulia AR, Manno EM, Derdeyn CP, Adams RE, Diringer MN, et al. Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001;57:2120-2.
  • 21 Bacher A, Wei J, Grafe MR, Quast MJ, Zornow MH. Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline. Crit Care Med 1998;26:108-14.
  • 22 Muizelaar JP, Wei EP, Kontos HA, Becker DP. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983;59:822-8.
  • 23 Sorani MD, Manley GT. Dose-response relationship of mannitol and intracranial pressure: A metaanalysis. J Neurosurg 2008;108:80-7.
  • 24 Guidelines for the management of severe head injury: Resuscitation of blood pressure and oxygenation. J Neurotrauma 1996;13:661-6.
  • 25 Committee on Trauma. Shock. In: Advanced Trauma Life Support Program. Chicago, Ill: American College of Surgeons; 1989. p. 57-73.
  • 26 Shenkin HA, Bouzarth WF, Tatsumi T. The analysis of body water compartments in postoperative craniotomy patients. Part 1. The effects of major brain surgery alone. Part 2. The effects of mannitol administered preoperatively. J Neurosurg 1967;28:417-28.
  • 27 Shenkin HA, Gutterman P. The analysis of body water compartments in postoperative craniotomy patients 3. The effects of dexamethasone. J Neurosurg 1969;31:400-7.
  • 28 Shackford SR, Norton CH, Todd MM. Renal, cerebral, and pulmonary effects of hypertonic resuscitation in a porcine model of hemorrhagic shock. Surgery 1988;104:553-60.
  • 29 Velasco IT, Pontieri V, Rocha e Silva M Jr., Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 1980;239:H664-73.
  • 30 Nakayama S, Sibley L, Gunther RA, Holcroft JW, Kramer GC. Small-volume resuscitation with hypertonic saline (2,400 mOsm/liter) during hemorrhagic shock. Circ Shock 1984;13:149-59.
  • 31 Arlinghaus KA, Shoaib AM, Price TR. Neuropsychiatric assessment. In: Silver JM, McAllister TW, Yudofsky SC, editors. Textbook of Traumatic Brain Injury. Washington, DC: American Psychiatric Association; 2005. p. 59-62.
  • 32 Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: Lactated ringer's solution versus hypertonic saline. Crit Care Med 1998;26:1265-70.
  • 33 Qureshi AI, Suarez JI, Castro A, Bhardwaj A. Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: Experience at a single center. J Trauma 1999;47:659-65.
  • 34 Shackford SR, Bourguignon PR, Wald SL, Rogers FB, Osler TM, Clark DE, et al. Hypertonic saline resuscitation of patients with head injury: A prospective, randomized clinical trial. J Trauma 1998;44:50-8.
  • 35 Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: A randomized controlled trial. JAMA 2004;291:1350-7.
  • 36 Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: A randomized controlled trial. JAMA 2010;304:1455-64.
  • 37 Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992;3:12-27.
  • 38 Verbalis JG. Brain volume regulation in response to changes in osmolality. Neuroscience 2010;168:862-70.
  • 39 Cserr HF. Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation. Ann N Y Acad Sci 1988;529:9-20.
  • 40 Mendez MF. The neuropsychiatric aspects of boxing. Int J Psychiatry Med 1995;25:249-62.
  • 41 Holliday MA, Kalayci MN, Harrah J. Factors that limit brain volume changes in response to acute and sustained hyper – And hyponatremia. J Clin Invest 1968;47:1916-28.
  • 42 Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT, et al. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: A preliminary study. Neurosurgery 2005;57:727-36.
  • 43 Kerwin AJ, Schinco MA, Tepas JJ 3rd, Renfro WH, Vitarbo EA, Muehlberger M, et al. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: A pilot study. J Trauma 2009;67:277-82.
  • 44 Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998;26:1118-22.
  • 45 Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Jancik JT, Quickel RR, et al. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery 2009;65:1035-41.
  • 46 Paredes-Andrade E, Solid CA, Rockswold SB, Odland RM, Rockswold GL. Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities. Neurocrit Care 2012;17:204-10.
  • 47 DeWitt DS, Prough DS, Deal DD, Vines SM, Hoen H. Hypertonic saline does not improve cerebral oxygen delivery after head injury and mild hemorrhage in cats. Crit Care Med 1996;24:109-17.
  • 48 Weinstsabl C, Mayer N, Germann P, Steltzer H, Hammerle AF. Hypertonic, hyperoncotic hydroxyethyl starch decreases intracranial pressure following neurotrauma. Anesthesiology 1991;75:A202.
  • 49 Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992;4:4-10.